Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients

Backgrounds and PurposeConcurrent non-alcoholic fatty liver disease (NAFLD) in chronic hepatitis B (CHB) patients is a frequent and increasingly concerning problem because of the NAFLD pandemic. Admittedly, NAFLD can progress to non-alcoholic steatohepatitis (NASH) and severe fibrosis. Direct eviden...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yan Huang, Qinyi Gan, Rongtao Lai, Weijing Wang, Simin Guo, Zike Sheng, Lu Chen, Qing Guo, Wei Cai, Hui Wang, Gangde Zhao, Zhujun Cao, Qing Xie
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2022-01-01
Serie:	Frontiers in Cellular and Infection Microbiology
Soggetti:	hepatitis B non-alcoholic fatty liver disease (NAFLD) non-alcoholic steatohepatitis (NASH) liver biopsy liver fibrosis
Accesso online:	https://www.frontiersin.org/articles/10.3389/fcimb.2021.733348/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!